Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Violeta Sánchez et al.|Nature Communications|2016Cited by 572
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epitheliumJustin M. Balko, Rebecca S. Cook, Todd W. Miller et al.|Proceedings of the National Academy of Sciences|2011Cited by 75